Mutations in the MYH9 gene encoding non-muscle myosin IIA lead to macrothrombocytopenia as observed in MYH9-related disorders. We used mice with megakaryocyte-restricted MYH9 inactivation to explore the role of myosin in thrombopoiesis.
Introduction
Non-muscle myosin IIA plays a fundamental role in basic cellular functions such as cell division, adhesion to extracellular matrices and migration 1 . The myosin IIA heavy chain is encoded by the MYH9 gene and is the only isoform of non-muscle myosin II present in blood platelets, unlike most cells which also express myosin IIB 2 . Mutations in the MYH9 gene lead to dominant hereditary hemorrhagic diseases known as MYH9-related disorders (MYH9-RD, previously classified as the May-Hegglin anomaly and the syndromes of Sebastian, Fechtner and Epstein) characterized by congenital thrombocytopenia with large platelets (macrothrombocytopenia) and leukocyte inclusions, sometimes associated with loss of hearing, cataracts or nephritis during childhood and/or adulthood 3, 4 . The origin of the thrombocytopenia is unknown but most probably results from defective thrombopoiesis since the platelet half-life appears to be either normal or only slightly decreased in these patients 5, 6 .
Blood platelets are produced by megakaryocytes following differentiation and maturation of hematopoietic stem cells into giant polyploid cells 7, 8 . The ultrastructure of these mature megakaryocytes reveals a large and highly organized cytoplasm 9, 10 . The granular zone contains an extensive membrane network called the demarcation membrane system (DMS) which constitutes a membrane reservoir for the future platelets 11 , while the actin-rich peripheral zone is devoid of DMS and organelles 9, 10, 12 . It is now thought that mature megakaryocytes release platelets through extension of cytoplasmic projections, the socalled proplatelets, into the vessel lumen 13, 14 .
The role of myosin IIA in platelet biogenesis is still poorly understood and only a few reports are available concerning the impact of myosin IIA mutations on the bone marrow megakaryocytes of MYH9-RD patients. These individuals have either a normal or an increased number of megakaryocytes 6, [15] [16] [17] and normal megakaryocyte DNA ploidy 16, 18 .
Recently, two separate in vitro studies using megakaryocytes differentiated from mouse
For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From embryonic stem cells or human CD34+ cells described the involvement of the Rho-Rho kinase-MLC-myosin IIA pathway in proplatelet formation 19, 20 . Inhibition of this pathway at either level resulted in enhanced proplatelet formation, suggesting myosin to be a negative regulator of platelet production. This may seem somewhat paradoxical in view of the macrothrombocytopenia in MYH9-RD patients and provides no explanation as to how the increased proplatelet formation translates into thrombocytopenia.
In order to gain insight into the mechanisms controlling the involvement of myosin IIA in platelet formation, we used the previously described megakaryocyte-restricted myosindeficient mice (MYH9Δ mice) 21 . These animals exhibit severe myosin IIA deficiency and important hemostatic defects due to absence of the platelet contractile shape change and outside-in signaling. As in the human patients, MYH9Δ mice are thrombocytopenic and have large platelets 21 . These platelets appear heterogeneous with a mixed population of normal discoid and more ovoid cells, a large proportion of them containing high amounts of rough endoplasmic reticulum 21 . A normal number of microtubule coils was observed in both discoid and ovoid platelets, contrary to what was previously reported for giant platelets from patients with May-Hegglin anomaly and Epstein's syndrome where the number of coils was increased 10-20 fold 22 . Strikingly, at the ultrastructural level, some of the MYH9Δ platelets appear crowded with organelles while others appear devoid of organelles, strongly suggesting a role for myosin IIA in the granule distribution 21 . In the present study, the megakaryocytes of MYH9Δ bone marrow were examined in situ and the role of myosin IIA in matrix-induced cytoskeletal reorganization and in proplatelet formation was investigated in vitro using bone marrow-derived cultured megakaryocytes.
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Materials and Methods

Materials.
Equine tendon collagen was from Nycomed (Munich, Germany). RNAse A, propidium iodide, BSA and polyclonal anti-myosin IIA antibodies were from Sigma-Aldrich (Rueil-Malmaison, France). Anti-mouse β3 integrin (LucA5) was from Emfret (Wurzburg, Germany). Complete protease inhibitor cocktail, phalloidin-AF488, goat anti-rabbit AF488 ou AF555, goat anti-rat AF555, IMDM medium, penicillin, streptomycin and glutamine were from Invitrogen (Cergy-Pontoise, France). A FITC-labeled monoclonal anti-CD41 antibody was from Emfret (Wurtzburg, Germany) and recombinant hTPO was from Stem Cell (Vancouver, Canada).
Mice. The floxed MYH9 strain was crossed with PF4-Cre mice 23 to obtain mice with deletion of the MYH9 exon 1 in the megakaryocytic lineage, as described previously 21 . Homozygous wild-type (WT) and MYH9Δ littermates used in this study were from a mixed C57BL/6-129sv genetic background and were maintained in the animal facilities of the Etablissement Français du Sang-Alsace. For the measurement of circulating TPO level, blood was drawn from the abdominal aorta and anticoagulated with EDTA (6mM). Plasma was obtained after centrifugation of whole blood at 10 000 rpm and the TPO level was measured using the mouse TPO Quantikine Elisa kit (R&D systems, Lille, France). All experiments with mice conformed to French legislation for animal experimentation and followed the recommendations of the Guide for Care and Use of Laboratory at the Institute of Laboratory Animal Resources.
In situ megakaryocytes
Bone marrow histology. ) by measuring the perimeter of the electron lucent zones, where the perimeter corresponds to the demarcation membranes.
The perimeter was determined in pixels using Metamorph TM software (Version 5; Universal
Imaging Corporation, Downingtown, PA). A total of 23 megakaryocytes from 3 different mice were analyzed for both the WT and the MYH9Δ strain.
Myosin IIA immunolabeling of bone marrow megakaryocytes
Confocal imaging. Bone marrow samples were fixed in 4% PFA, cryopreserved by sucrose immersion and frozen. Cryosections (8 µm) were cut with a cryocut (Leica CM 3050 S) and incubated with a polyclonal anti-myosin IIA antibody (10 µg/mL) followed by a secondary AF488-conjugated goat anti-rabbit antibody. In some cases, double labeling was performed with anti-β3 integrin antibody followed by secondary AF555-conjugated goat anti-rat antibody. The slides were mounted with Mowiol and examined under a confocal microscope (TCS SP5, objective 63X/1.4 oil; Leica Microsystems, France).
TEM. Bone marrow cells were fixed in 2% PFA and embedded in Lowicryl 25 . Sections were first incubated with anti-myosin or irrelevant antibodies (10 µg/mL) followed by 10 nm goldconjugated Protein A and then stained with 1.8% uranyl acetate/0.2% methylcellulose. In some experiments, to visualize intracellular cytoskeletal filaments, bone marrow cells were permeabilized with 0.02% saponin for 5 min, fixed in 2% PFA and labeled in suspension 26 .
The cells were incubated overnight with anti-myosin or irrelevant antibodies (10 µg/mL) followed by 10 nm gold-conjugated Protein A and the samples were embedded in epon.
In vitro megakaryocytes
Culture. Mouse bone marrow was flushed from femurs and tibias with Tyrode's buffer. The cells were then dissociated and cultured in IMDM medium supplemented with 5% fetal bovine serum, 2 mmol/L L-glutamine, 50 U/mL penicillin, 50 µg/mL streptomycin and 50 ng/mL TPO. After 3 days culture, mature megakaryocytes were recovered by passing the suspension through a discontinuous density BSA gradient. Several photographs of the same cell were taken on different focal planes so as to permit the analysis of 1 to 4 isolated buds per megakaryocyte. A total of 58 and 65 megakaryocytes were examined for WT and MYH9Δ mice, respectively, from three independent cultures. In order to observe megakaryocytes forming proplatelets by scanning electron microscopy, the cells were recovered after fixation in 2% PFA and cytospun onto poly-L-lysine-coated slides 21 .
Results
The thrombocytopenia of MYH9Δ mice does not result from a defect in megakaryocyte number or ploidy As previously described 21 , MYH9Δ mice exhibit a 70% decrease in the circulating platelet count with a normal platelet half-life. To determine which steps in the platelet production process are affected by MYH9 inactivation, we first examined bone marrow by conventional histology. Whereas WT megakaryocytes appeared as giant round cells (Fig. 1A, left) , MYH9Δ megakaryocytes seemed to be diffuse and it was difficult to precisely delimit their contours (Fig. 1A, right) . In order to identify all megakaryocytes, the cells were further examined by immunofluorescence histology after labeling with antibodies against integrin β3 and VWF. In this case, the infiltrating morphology of MYH9Δ megakaryocytes was even more evident, as compared to that of WT megakaryocytes which appeared as well delineated isolated cells (Supplementary data, Fig. S1 ). As a result, MYH9Δ megakaryocytes were hard to count under the optical microscope and we counted them by TEM observation of bone marrow sections.
The number of megakaryocytes from stages I to III was significantly increased (1.5 fold) in MYH9Δ as compared to WT mice (Fig. 1B) . This increase is probably due to reactive thrombocytopoiesis. Indeed, the level of circulating TPO is increased in MYH9Δ mouse plasma (mean±sem 209.9±10.7 and 301.8±33.6 pg/mL for WT and MYH9Δ plasma, respectively, n=9, p=0.0192 with unpaired Student's t-test).
DNA ploidy was determined as a marker of megakaryocyte differentiation. In the CD41+ population, a ploidy of up to 64N was observed in both WT and MYH9Δ cells (Fig.1C) , without any difference in ploidy distribution (Fig. 1D) . Overall, these data indicate that the thrombocytopenia of MYH9Δ mice is unlikely to result from a reduced number of megakaryocytes or defects in endoreplication.
MYH9Δ mice display an abnormal megakaryocyte morphology with a decreased DMS
At the ultrastructural level, the abnormal shape of mature MYH9Δ megakaryocytes was even more striking ( Fig. 2A, right) . These cells appear to infiltrate without restraint between the other bone marrow cells. In addition, the cytoplasm of MYH9Δ megakaryocytes is totally disorganized as compared to that of the WT. Whereas mature WT megakaryocytes display a distinct granular zone containing a well-developed DMS and a peripheral zone (PZ)
devoid of DMS and organelles ( Fig. 2A, left) , no peripheral zone can be distinguished in MYH9Δ megakaryocytes ( Fig. 2A, right) . Moreover, the DMS of the latter is highly disorganized being dilated with a vacuole-like appearance and containing very few welldelimited platelet territories (PT) ( Fig. 2A, right) . Image analysis was used to measure the perimeter of the DMS area and determine the amount of internal membrane (see Methods)
( Fig. 2B) . The internal membranes were found to be 1.7 times less developed in MYH9Δ megakaryocytes than in WT cells (Fig. 2C ). These in situ data indicate that myosin is involved in maintenance of the cell shape and the intracytoplasmic organization of the DMS and peripheral zone in megakaryocytes.
Myosin IIA is concentrated at the periphery of WT megakaryocytes and is in contact with the DMS
In order to identify the site where myosin could act, we next examined the distribution of myosin in WT megakaryocytes using immunolabeling and confocal and transmission electron microscopy. As shown in Figure 3A , myosin is distributed throughout the cytoplasm with a particularly high concentration at the periphery of the cell. This corresponds to the presence of thick myosin filaments as revealed by TEM using gold-labeled antibodies (Fig. 
3B, arrowheads). These filaments form a continuous network which entirely surrounds the
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From granular zone and borders the peripheral zone (Fig. 3B) . Myosin is also detected within the peripheral zone (PZ) and appears to be in contact with actin filaments (Fig. 3B, arrows) . The peripheral zone is absent from MYH9Δ megakaryocytes, strongly suggesting that the network of myosin is necessary to separate the cytoplasm into a peripheral and a granular zone. In addition, myosin is present near and in contact with the DMS (Fig. 3C, arrows) , suggesting it to be directly involved in the development and organization of these membranes.
Careful examination of MYH9Δ megakaryocytes revealed the presence of residual myosin forming clusters in the cytoplasm (Fig. S2A) . Western blot experiments performed on cultured cells showed that MYH9Δ megakaryocytes express less than 1% of residual normalsized myosin (Fig. S2B, arrowhead) together with a lower molecular weight myosin, probably the truncated protein lacking exon 1, which amounted to 17% of control platelets (Fig. S2B,   arrow) . These results confirm previous observations in circulating platelets 21 and as in platelets, the residual amounts of myosin are not able to support a contractile function (see below).
MYH9Δ megakaryocytes are unable to form stress fibers upon adhesion to fibrillar collagen
If the peripheral zone is involved in maintaining a round shape, its absence in MYH9Δ megakaryocytes could contribute to their tendency to leak between other cells. Another nonexclusive explanation for the MYH9Δ morphology could be a defect in the interaction of these cells with the stroma. To investigate this point, we performed in vitro adhesion assays on collagen, one of the principal matrix proteins found in bone marrow. Bone marrow-derived megakaryocytes cultured for 3 days were allowed to adhere to collagen-coated coverslips for 3 hours. Adhesion led to cell spreading and reorganization of the actin cytoskeleton. In WT cells, the actin filaments were organized in bundles anchored at the cell periphery and were
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From present throughout the cell body, forming stress fibers interacting with myosin which was found along the actin fibers (Fig. 4A-C) . In contrast, stress fibers were absent from MYH9Δ megakaryocytes (Fig. 4D-F) and although actin filaments were present, they were randomly distributed throughout the whole cell. Hence the loose, poorly delimited aspect of MYH9Δ megakaryocytes could result at least in part from defective signaling between the cells and their extracellular environment.
Proplatelet formation is abnormal and enhanced in MYH9Δ megakaryocytes
The efficacy of the intrinsic thrombopoiesis of megakaryocytes was further examined in vitro using bone marrow-derived cells cultured in a liquid medium for 4 days in the presence of thrombopoietin. Under these conditions, 9% of WT megakaryocytes formed proplatelets as counted on DIC microscopy images of live cells (Fig. 5A, D) . In MYH9Δ megakaryocyte cultures the proportion of cells extending proplatelets was considerably higher, with levels of up to 25% (Fig. 5B, C (Fig. 5D ) 13 . Conversely, the proplatelets formed by MYH9Δ megakaryocytes had a heterogeneous morphology, sometimes resembling a bunch of grapes (Fig. 5E ). Another feature of these proplatelets was the increased size of the proplatelet buds and intermediate swellings, which is reminiscent of the greater size of the circulating platelets (Fig. 5F ).
Discussion
In the present study, we explored the role of myosin in thrombocytopoiesis using megakaryocyte-restricted myosin IIA-deficient mice. We provide evidence for a role of myosin IIA in megakaryocyte development through its participation in the maintenance of cell shape, formation and organization of the DMS and the peripheral zone, anchorage to the extracellular matrix and proplatelet formation.
The most striking defects observed in the bone marrow are the abnormal shape and irregular aspect of mature MYH9Δ megakaryocytes. In situ, cell morphology is controlled by intracellular cytoskeletal tensions and adhesive interactions with the extracellular environment. Stress fibers are absent from adherent MYH9Δ megakaryocytes, suggesting that both internal tensions and focal adhesions are strongly perturbed. Previous in vitro studies in non-megakaryocytic cell types have demonstrated the importance of myosin IIA for normal cell shape through its involvement in the formation of stress fibers and focal adhesions, with ablation of myosin IIA leading to unusually large membrane protrusions [27] [28] [29] . Thus, a lack of internal tension and proper interaction with the extracellular matrix is probably responsible for the leaky shape of MYH9Δ megakaryocytes in the bone marrow.
In addition to their irregular appearance, the overall cytoplasmic organization is perturbed in MYH9Δ megakaryocytes. Firstly, the DMS is less abundant and abnormally dilated. This clearly indicates that myosin itself is directly required to achieve normal DMS development and organization, a conclusion which is further supported by our observation that myosin is associated with the DMS in WT megakaryocytes. During elaboration of the DMS, phosphatidylinositol 4,5-bisphosphate accumulates at the cytoplasmic face of these membranes and promotes the local assembly of actin filaments 11 . Hence actomyosin could be necessary to apply a contractile force to the membranes and thereby organize and stabilize the DMS in maturing megakaryocytes.
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A second observation is the absence of a peripheral zone in MYH9Δ megakaryocytes due to the absence of the myosin filament network surrounding the granular zone. The role of the peripheral zone is still unknown. It has been suggested that a wide peripheral zone is characteristic of more mature megakaryocytes 30 and could play a role in the association of the cells with the sinusoid subendothelium 31 . Tablin How then does a lack of myosin, which increases the amount of megakaryocytes extending proplatelets in vitro, result in thrombocytopenia in vivo? One hypothesis could be that a premature release of platelets before the megakaryocyte has reached full maturity would lead to a decrease in circulating platelets. Such a premature platelet release has indeed been observed in WASP-deficient mice where platelets were frequently found in the marrow interstitium 33 . However, electron microscopy never revealed released platelets outside the vasculature in MYH9Δ mice, suggesting that the mechanism of thrombocytopenia may be different in this case. Another hypothesis is based on the observation that in situ, the DMS is reduced in MYH9Δ megakaryocytes. Whether this lesser development of the DMS reflects an immature state of the MYH9Δ cells or a decreased capacity to generate these membranes is still unclear. Since the DMS is known to be the only source of proplatelet membranes 11 , our observations could at least partly explain the thrombocytopenia found in MYH9Δ mice as being due to the lack of a sufficient membrane reservoir for platelet formation. The fact that proplatelet extensions are possible in MYH9Δ megakaryocytes does not preclude the possibility that the number of platelets produced per megakaryocyte is reduced due to the smaller amount of DMS. In this regard, a link between underdeveloped/disorganized DMS and thrombocytopenia has been reported in various genetically engineered mouse strains such as GPIbα-, GATA1-and NF-E2-deficient mice [34] [35] [36] and strains overexpressing transcription factor E2F-1 37 .
Overall, this study provides further evidence that myosin is involved in different steps of thrombocytopoiesis. Whether all or only some of these steps are affected in MYH9-RD patients remains to be determined. Although few data are available concerning the ultrastructure of MYH9-RD megakaryocytes in situ, some ultrastructural abnormalities have been reported in megakaryocytes from patients with Fechtner, Sebastian and May-Hegglin syndromes 15, 18, 38 . In all cases the DMS was arranged in a disorderly fashion with poorly demarcated platelet fields, either being concentrated in areas devoid of organelles or radiating from the core of the cell to its periphery 15, 18, 38 . The peripheral zone was also affected and in some cells reduced to a narrow rim with frequent openings 18 . These findings suggest that, although myosin IIA-deficient mice are not the exact model of MYH9-RD, the defects in cytoplasmic organization seen in MYH9-RD and MYH9Δ megakaryocytes are a common consequence of the impairment of myosin activity.
In summary, we show that myosin is required to maintain megakaryocyte shape through internal tension and anchorage to the extracellular matrix. Our data also strongly suggest that myosin is directly involved in formation/stabilization of the DMS. Finally,
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From myosin is seen to play a crucial role in the organization of the cytoplasm into granular and peripheral zones and our results lead to the hypothesis that the presence of a peripheral zone in megakaryocytes could be a determining factor for the extension of proplatelets. 
